Topical pharmaceutical (alpha-agonist)
Oxymetazoline hydrochloride [USAN:JAN]
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
An alpha-adrenergic vasoconstrictor approved as a prescription drug (Rhofade) for persistent rosacea facial redness in adults. Not intended for general cosmetic use without medical supervision.
Skin benefits
- Highly effective vasoconstrictor that reduces facial erythema
- Used as prescription medicine for persistent rosacea redness
Known concerns
- Prescription pharmaceutical, not a cosmetic ingredient
- Alpha-adrenergic agonist with potential cardiovascular effects
- Risk of rebound redness and worsening of symptoms
- Use outside medical supervision is inappropriate
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Check your shelf
Find Oxymetazoline hydrochloride [USAN:JAN] in your products.
Scan any cosmetic product with LuxSense to see if it contains Oxymetazoline hydrochloride [USAN:JAN] and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.